Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | RARB | P10826 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12956861 | 1.00 | NAAA (0.64) | NAAAHTTRAD52NPSR1RARB | |
| SCHEMBL31073525 | 1.00 | NAAA (0.64) | NAAAHTTRAD52NPSR1RARB | |
| SCHEMBL15130550 | 1.00 | NAAA (0.64) | NAAAHTTRAD52NPSR1RARB | |
| SCHEMBL544669 | 1.00 | NAAA (0.64) | NAAAHTTRAD52NPSR1RARB | |
| SCHEMBL29190764 | 1.00 | NAAA (0.64) | NAAAHTTRAD52NPSR1RARB | |
| SCHEMBL3506195 | 1.00 | NAAA (0.64) | NAAAHTTRAD52NPSR1RARB | |
| SCHEMBL12956395 | 1.00 | NAAA (0.64) | NAAAHTTRAD52NPSR1RARB | |
| SCHEMBL8985716 | 0.98 | NAAA (0.61) | NAAAHTTRAD52NPSR1RARB | |
| Propionic Acid SCHEMBL28694385 | 0.94 | NAAA (0.58) | NAAAHTTRAD52NPSR1RARB | |
| SCHEMBL15130556 | 0.93 | NAAA (0.56) | NAAAHTTHTR2CDGKADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116947951-A | Compound with STING channel activating function and application thereof | 成都威斯津生物医药科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116947951-A | Compound with STING channel activating function and application thereof | 成都威斯津生物医药科技有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-104513463-B | Resin combination, thiapyran class side acid compound and image forming material | 富士施乐株式会社 | 2018-09-25 | — | — | CN | disclosed |
| US-9760034-B2 | Resin composition, thiopyran-based squarylium compound and image forming material | FUJI XEROX CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| CN-104513463-A | Resin composition, thiopyran-based squarylium compound and image forming material | FUJI XEROX CO LTD | 2015-04-15 | — | — | CN | disclosed |
| US-20150093698-A1 | RESIN COMPOSITION, THIOPYRAN-BASED SQUARYLIUM COMPOUND AND IMAGE FORMING MATERIAL | FUJI XEROX CO., LTD. (JP) | 2015-04-02 | — | — | US | disclosed |
| CN-101278051-B | Personal care compositions and methods of use thereof | GENENCOR INT | 2011-10-05 | — | — | CN | disclosed |
| CN-101278051-A | Personal care compositions and methods of use thereof | GENENCOR INT (US) | 2008-10-01 | — | — | CN | disclosed |
| US-4035409-A | MOTOR FUEL | TEXACO INC. (US) | 1977-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150093698-A1 | RESIN COMPOSITION, THIOPYRAN-BASED SQUARYLIUM COMPOUND AND IMAGE FORMING MATERIAL | SYMPK, TIPRL, SLC35B2 | NAAA 1167/4885HTT 1318/4885RAD52 1733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.